.jpg)
As early as the beginning of 2014, health care packaging publisher Jim Chrzan and your true travel to Washington, DC, stopped at the African Medicines Board, the US Pharmacopoeia Convention, the Regulatory Affairs Professional Association and the Consumer Product Safety Commission to understand and report on these organizations with Life Sciences Packaging related to the development.
Child-resistant packaging (CRP), which continues to evolve, was often addressed during our “Healthcare Packaging goes to Washington” tour, particularly at CPSC and RAPS.
On August 2, RAPS reported that the FDA “published draft guidance to help ensure child-resistant packaging statements in drug labels [are] clear, useful, informative and, to the extent possible, consistent in content and format.”
FDA’s “Child-Resistant Packaging Statements in Drug Product Labeling—Guidance for Industry,” welcomes comments and suggestions submitted within 60 days of publication in the Federal Register.
Provide background information, guidance is to protect children and the development of the "1970 anti-virus packaging law." The guide deals with household items, including most oral prescriptions and many non-prescription drugs. The guide further reports on the labeling, drug storage, and the presentation of the presentation on the CRP label.
Article from:
https://www.packworld.com/
